---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-011826"
form_type: "8-K"
ticker: "GRDN"
cik: "0001802255"
company_name: "Guardian Pharmacy Services, Inc."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:41:46.876305+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Guardian reiterates 2025 guidance, provides 2026 outlook with ~11% adj. EBITDA growth

## Summary
- Reaffirmed 2025 revenue $1.43B-$1.45B and adjusted EBITDA $104M-$106M.
- 2026 outlook: revenue $1.40B-$1.42B (down due to IRA drug price cuts) and adjusted EBITDA $115M-$118M.
- 2026 adjusted EBITDA margin expected above 8%, structural improvement from 2025.
- Completed year-end acquisition of a single pharmacy in Montana, adding new territory.
- CEO expects low double-digit adjusted EBITDA growth despite mandatory price reductions.

## SEC filing metadata
- accession: 0001193125-26-011826
- form_type: 8-K
- ticker: GRDN
- cik: 0001802255
- company_name: Guardian Pharmacy Services, Inc.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/0001193125-26-011826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/d824523d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-011826
- JSON: https://secwatch.observer/filing/0001193125-26-011826.json
- Plain text: https://secwatch.observer/filing/0001193125-26-011826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.